137 related articles for article (PubMed ID: 15897325)
1. Selection of novel mediators of E2F1-induced apoptosis through retroviral expression of an antisense cDNA library.
Li Z; Stanelle J; Leurs C; Hanenberg H; Pützer BM
Nucleic Acids Res; 2005; 33(9):2813-21. PubMed ID: 15897325
[TBL] [Abstract][Full Text] [Related]
2. A novel mitochondrial protein DIP mediates E2F1-induced apoptosis independently of p53.
Stanelle J; Tu-Rapp H; Pützer BM
Cell Death Differ; 2005 Apr; 12(4):347-57. PubMed ID: 15565177
[TBL] [Abstract][Full Text] [Related]
3. Novel link between E2F and p53: proapoptotic cofactors of p53 are transcriptionally upregulated by E2F.
Hershko T; Chaussepied M; Oren M; Ginsberg D
Cell Death Differ; 2005 Apr; 12(4):377-83. PubMed ID: 15706352
[TBL] [Abstract][Full Text] [Related]
4. E2F1 uses the ATM signaling pathway to induce p53 and Chk2 phosphorylation and apoptosis.
Powers JT; Hong S; Mayhew CN; Rogers PM; Knudsen ES; Johnson DG
Mol Cancer Res; 2004 Apr; 2(4):203-14. PubMed ID: 15140942
[TBL] [Abstract][Full Text] [Related]
5. Direct repression of the Mcl-1 promoter by E2F1.
Croxton R; Ma Y; Song L; Haura EB; Cress WD
Oncogene; 2002 Feb; 21(9):1359-69. PubMed ID: 11857079
[TBL] [Abstract][Full Text] [Related]
6. Improved safety through tamoxifen-regulated induction of cytotoxic genes delivered by Ad vectors for cancer gene therapy.
Pützer BM; Stiewe T; Crespo F; Esche H
Gene Ther; 2000 Aug; 7(15):1317-25. PubMed ID: 10918503
[TBL] [Abstract][Full Text] [Related]
7. Identification of novel E2F1-regulated genes by microarray.
Ma Y; Croxton R; Moorer RL; Cress WD
Arch Biochem Biophys; 2002 Mar; 399(2):212-24. PubMed ID: 11888208
[TBL] [Abstract][Full Text] [Related]
8. Bcl-2 is an apoptotic target suppressed by both c-Myc and E2F-1.
Eischen CM; Packham G; Nip J; Fee BE; Hiebert SW; Zambetti GP; Cleveland JL
Oncogene; 2001 Oct; 20(48):6983-93. PubMed ID: 11704823
[TBL] [Abstract][Full Text] [Related]
9. Conditional E2F1 activation in transgenic mice causes testicular atrophy and dysplasia mimicking human CIS.
Agger K; Santoni-Rugiu E; Holmberg C; Karlström O; Helin K
Oncogene; 2005 Jan; 24(5):780-9. PubMed ID: 15531911
[TBL] [Abstract][Full Text] [Related]
10. Functional interplay between p53 and E2F through co-activator p300.
Lee CW; Sørensen TS; Shikama N; La Thangue NB
Oncogene; 1998 May; 16(21):2695-710. PubMed ID: 9652736
[TBL] [Abstract][Full Text] [Related]
11. Activation of ARF by oncogenic stress in mouse fibroblasts is independent of E2F1 and E2F2.
Palmero I; Murga M; Zubiaga A; Serrano M
Oncogene; 2002 May; 21(19):2939-47. PubMed ID: 12082524
[TBL] [Abstract][Full Text] [Related]
12. Proteomic analysis of the E2F1 response in p53-negative cancer cells: new aspects in the regulation of cell survival and death.
Li Z; Kreutzer M; Mikkat S; Mise N; Glocker MO; Pützer BM
Proteomics; 2006 Nov; 6(21):5735-45. PubMed ID: 17001603
[TBL] [Abstract][Full Text] [Related]
13. E2F1 mediates ectopic proliferation and stage-specific p53-dependent apoptosis but not aberrant differentiation in the ocular lens of Rb deficient fetuses.
Liu Y; Zacksenhaus E
Oncogene; 2000 Dec; 19(52):6065-73. PubMed ID: 11146559
[TBL] [Abstract][Full Text] [Related]
14. The transcription factor E2F1 promotes dopamine-evoked neuronal apoptosis by a mechanism independent of transcriptional activation.
Hou ST; Cowan E; Walker T; Ohan N; Dove M; Rasqinha I; MacManus JP
J Neurochem; 2001 Jul; 78(2):287-97. PubMed ID: 11461964
[TBL] [Abstract][Full Text] [Related]
15. Caspase activation and changes in Bcl-2 family member protein expression associated with E2F-1-mediated apoptosis in human esophageal cancer cells.
Yang HL; Dong YB; Elliott MJ; Liu TJ; McMasters KM
Clin Cancer Res; 2000 Apr; 6(4):1579-89. PubMed ID: 10778992
[TBL] [Abstract][Full Text] [Related]
16. Inactivating E2f1 reverts apoptosis resistance and cancer sensitivity in Trp53-deficient mice.
Wikonkal NM; Remenyik E; Knezevic D; Zhang W; Liu M; Zhao H; Berton TR; Johnson DG; Brash DE
Nat Cell Biol; 2003 Jul; 5(7):655-60. PubMed ID: 12833065
[TBL] [Abstract][Full Text] [Related]
17. E2F1 up-regulates the expression of the tumour suppressor axin2 both by activation of transcription and by mRNA stabilisation.
Hughes TA; Brady HJ
Biochem Biophys Res Commun; 2005 Apr; 329(4):1267-74. PubMed ID: 15766563
[TBL] [Abstract][Full Text] [Related]
18. Specificity in the activation and control of transcription factor E2F-dependent apoptosis.
Hallstrom TC; Nevins JR
Proc Natl Acad Sci U S A; 2003 Sep; 100(19):10848-53. PubMed ID: 12954980
[TBL] [Abstract][Full Text] [Related]
19. Down-regulation of c-myc and Cyclin D1 genes by antisense oligodeoxy nucleotides inhibits the expression of E2F1 and in vitro growth of HepG2 and Morris 5123 liver cancer cells.
Simile MM; De Miglio MR; Muroni MR; Frau M; Asara G; Serra S; Muntoni MD; Seddaiu MA; Daino L; Feo F; Pascale RM
Carcinogenesis; 2004 Mar; 25(3):333-41. PubMed ID: 14604889
[TBL] [Abstract][Full Text] [Related]
20. Gene expression changes in response to E2F1 activation.
Stanelle J; Stiewe T; Theseling CC; Peter M; Pützer BM
Nucleic Acids Res; 2002 Apr; 30(8):1859-67. PubMed ID: 11937641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
